Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
20 drugs in development
By Therapeutic Area
top 6
R&D Momentum
88/100
Pipeline Velocity
62/100
Trial Completion Rate
73/100
Pipeline Concentration
19/100
Pipeline Freshness
59/100
Strategic Signals
Activity
Last 14 days
Post Acute Sequelae of SARS-CoV-2
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-related, Symptomatic Asthma (GATA-3)
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity
Individual vs Co-Treatment in Acute Stroke Rehabilitation and Evaluation
Maximizing Efficacy of Goal-Directed Sedation to Reduce Neurological Dysfunction in Mechanically Ventilated Infants and Children Study
VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)
Non-invasive Markers of Esophageal Function in Adults
Impact of Preoperative Respiratory Strength Training on Postoperative Health for Heart Transplant Recipients
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (With Baricitinib) for Long COVID Related Cognitive Impairment and ADRD (Alzheimer's Disease and Related Dementias)
Subcutaneous Tranexamic Acid in Nasal Mohs Local Flap Reconstruction: Perioperative Bleeding, Edema, and Ecchymosis
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)